|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 401/14 | |
| C07D 405/14 | |||
| C07D 401/12 | |||
| A61K 31/513 | |||
| A61K 31/501 | |||
| A61K 31/497 | |||
| A61P 25/00 |
| (11) | Patento numeris | 3013813 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14739554.5 |
| Europos patento paraiškos padavimo data | 2014-06-13 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-05-04 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-04-03 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/IB2014/062217 |
| Data | 2014-06-13 |
| (87) | Numeris | WO 2014/207601 |
| Data | 2014-12-31 |
| (30) | Numeris | Data | Šalis |
| 201361840144 P | 2013-06-27 | US |
| (72) |
BRODNEY, Michael Aaron, US
DAVOREN, Jennifer Elizabeth, US
DOUNAY, Amy Beth, US
EFREMOV, Ivan Viktorovich, US
GRAY, David Lawrence Firman, US
GREEN, Michael Eric, US
HENDERSON, Jaclyn Louise, US
LEE, Chewah, US
MENTE, Scot Richard, US
O`NEIL, Steven Victor, US
ROGERS, Bruce Nelsen, US
ZHANG, Lei, US
|
| (73) |
Pfizer Inc.,
235 East 42nd Street, New York, NY 10017,
US
|
| (54) | HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS |
| HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS |